Asiyah Yu Lin

Thank you @cthoyt and @rvita , I left the comment and questions at #1953 . Please let me know.

Suggest to follow the transparent PlosOne publish model. Whoever approved or dis-approve, can put their comment online and make it available for everyone to view.

Confirm that "patient screening" is very broad. If search google using "patient screening", there are multiple situations doing screening of patients: 1. clinical trial, 2. research study, 3. general cancer...

I think they are the same. It should be replaced.

What I read is that Anna Maria wants a mouse to bear the role of animal model. Besides the model output that is data, what about connecting the model organism...

@masciam based on your query, the disease is not what you want to link to. You want to link to failure mode -- I think that fits into the "target...

Discussed with Anna Maria on 7/7/2021: The request/use case is: in vivo/in vitro model - can be a cell line, animal, tissue sample, or single cell. [The definition of this...

Hi Bjoern, The data portion is fine. We could use that. But additionally, what I just summarized is the current use case.Please let me know what other actions we need...

Bjoern and OBI discuss, I agree with Bjoern's solution earlier as well, and if we can create role terms Anna Maria proposed, we could close the loop. Please advise. Thanks,...

I support the mapping work! The NIH CFDE has an ontology WG, they recognized both OBI and BAO for recommended ontologies. As there are overlaps between OBI and BAO, a...